←
Liver International2,159 posts
Liver International avatar

Liver International

@LiverInt

We publish high-quality original research in Hepatology / Co-EICs @lucavalenti75 @AghemoAlessio @Alexfornergon / IF=6.0 / RT ≠ endorsment

◷ Joined November 2012▧ 524 Photos and videos
Jonathan G. Stine, MD MSc, FACP avatar
⟳ Liver International retweeted
Jonathan G. Stine, MD MSc, FACP@JonathanStineMD·26 Dec 2024

🔥 🆙 to publish this work with @HD3vedi and team regarding the importance of #exercise across all types and stages of steatotic liver disease! Check it out here: onlinelibrary.wiley.com/doi/…

Yujun_Wong avatar
⟳ Liver International retweeted
Yujun_Wong@Yujun__Wong·16 Dec 2024

Anticoagulation did 🚫increase the risk of bleeding With/without anticoagulation during EVL, we found a similar risk of: 1) Overall bleeding 2) Severe bleeding 3) Post-banding ulcer bleeding #Livertwitter 👉doi.org/10.1111/liv.16188…

Post attachment

Indeed, the practice of anticoagulation is heterogeneous. We recently summarized the existing studies looking at the safety of anticoagulation in patients undergoing EVL 👉doi.org/10.1111/liv.16188 Anticoagulation did 🚫increase the risk of bleeding

Liver International avatar
Liver International@LiverInt·30 Nov 2024

2/2 💡 The clinical impact? Using genetics to interpret LBTs may reduce false positives/negatives, optimize resources, and improve diagnostics further validation in diverse populations is needed! 🌍🩺 #livertwitter

Post attachment
Josh Bilson avatar
⟳ Liver International retweeted
Josh Bilson@J_Bilson_·16 Nov 2024

The number and type of metabolic syndrome traits have important impacts on the risk of CKD and incident ESRD in people with MASLD. @EScorletti, @Alessan95336031, @LiverInt Read our recent work here: onlinelibrary.wiley.com/doi/…

Ezequiel Mauro avatar
⟳ Liver International retweeted
Ezequiel Mauro@ezemauro_ok·5 Nov 2024

🚨 Out now in @LiverInt: New scenarios in LT for HCC 👥 Led by a great international team in the field. @Alexfornergon @goncrespo1 @A_DAlessioMD @DJPinato @ColmeneroJordi @liverunitclinic @hospitalclinic @idibaps @BCLC_group @CHBPaulBrousse @HUReinaSofia onlinelibrary.wiley.com/doi/…

Angelo Armandi, MD, PhD avatar
⟳ Liver International retweeted
Angelo Armandi, MD, PhD@AngeloArmandi·18 Oct 2024

Our latest review on the impact of #PNPLA3 variants on clinical outcomes in #MASLD is out in @LiverInt open access @salvatore_petta @lucavalenti75 @stefano_romeo76 onlinelibrary.wiley.com/doi/…

Adriana Palom avatar
⟳ Liver International retweeted
Adriana Palom@adrianapalom24·16 Oct 2024

🔴Our work about the burden of hepatitis D in the context of reflex testing has received over 500 views since publication! 📃Read it here onlinelibrary.wiley.com/doi/… #ViewsMilestone @Mariabutif @AEEHLiver @LiverInt

Laura Turco avatar
⟳ Liver International retweeted
Laura Turco@Laura_Turco83·15 Oct 2024

What a news from @LiverInt! 🥳 Our review on CARVEDILOL IN PORTAL HYPERTENSION has received over 20,000 views since publication! 🥰 @ReibergerThomas @VincenzoLaMura @GiovanniVitale 🔽 onlinelibrary.wiley.com/doi/… #ViewsMilestone

Juan Turnes avatar
⟳ Liver International retweeted
Juan Turnes@jturnesv·11 Oct 2024

Necesidades no cubiertas en pacientes con hepatitis autoinmune (y son unas cuantas): 👉 Solo el 62% de los pacientes logran respuesta completa tras 1 año de tto ⚠️ Apenas el 27% lo consigue sin esteroides 🔄 30% de los pacientes cambian de tratamiento por intolerancia o no respuesta 📉 Heterogeneidad extrema en los tratamientos entre centros ❌ Necesitamos más alternativas terapéuticas efectivas y seguras 🔓 doi.org/10.1111/liv.16035 en @LiverInt Detalle relevante: tampoco debería sorprendernos, el tto estándar tiene 50 años! #livertwitter #HAI

Post attachmentPost attachment